Towards targeting the breast cancer immune microenvironment
- Author(s)
- Harris, MA; Savas, P; Virassamy, B; O'Malley, MMR; Kay, J; Mueller, SN; Mackay, LK; Salgado, R; Loi, S;
- Journal Title
- Nature Reviews Cancer
- Publication Type
- Review
- Abstract
- The tumour immune microenvironment is shaped by the crosstalk between cancer cells, immune cells, fibroblasts, endothelial cells and other stromal components. Although the immune tumour microenvironment (TME) serves as a source of therapeutic targets, it is also considered a friend or foe to tumour-directed therapies. This is readily illustrated by the importance of T cells in triple-negative breast cancer (TNBC), culminating in the advent of immune checkpoint therapy in combination with cytotoxic chemotherapy as standard of care for both early and advanced-stage TNBC, as well as recent promising signs of efficacy in a subset of hormone receptor-positive disease. In this Review, we discuss the various components of the immune TME in breast cancer and therapies that target or impact the immune TME, as well as the complexity of host physiology.
- Publisher
- Springer Nature
- Department(s)
- Laboratory Research
- Publisher's Version
- https://doi.org/10.1038/s41568-024-00714-6
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-01 04:53:00
Last Modified: 2024-08-01 05:00:54